MINERVA UROLOGICA E NEFROLOGICA, vol.68, no.2, pp.227-232, 2016 (SCI-Expanded)
Article / Article
MINERVA UROLOGICA E NEFROLOGICA
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Fibroblast growth factor 23, Ghrelin, Renal insufficiency, chronic, Uremia, RENAL-FAILURE, HYPERPHOSPHATEMIA, ATHEROSCLEROSIS, HEMODIALYSIS, ASSOCIATION, STOMACH
Bezmialem Vakıf University Affiliated:
BACKGROUND: Fibroblast growth factor (FGF)-23 is a recently discovered phosphaturic hormone that increases in chronic kidney disease (CKD). It has been accepted as a determinant of mortality and a therapeutic target in these patients. Ghrelin is a hormone that has roles in energy and nutrient metabolism. Ghrelin level was found to be increased in CKD patients. This is a controlled study in which the relationship between FGF-23 and ghrelin levels in CKD patients has been studied.